Eyeworld Daily News

EW SHOW DAILY 42 Meeting Reporter Tuesday, April 17, 2018 by Vanessa Caceres EyeWorld Contributing Writer (Bausch + Lomb), which Mitch Shultz, MD, Northridge, California, said helps to reduce post-occlusion surge and minimizes the amount of phaco energy needed. The Stellaris system also has the Vitesse vitrec- tomy platform. Robert Weinstock, MD, Largo, Florida, has found the Stellaris to be particularly helpful during refractive cataract surgery. Panelists presented details on the Victus 3.3 system (Bausch + Lomb) for femtosecond laser-assisted cataract surgery. Some of its bene- fits include a shorter phaco time, safety, and the ability to perform a precise capsulorhexis, Dr. Sheppard said. Although recent studies have not shown a benefit in always using femtosecond technology in phaco, Dr. Sheppard said it has some great advantages when you are able to use it. Having femtosecond tech- nology is a marketing tool when you perform many premium IOL insertions, said Dr. Stephenson, who also has found it helpful in dense or brunescent cataracts. A new software update for Victus makes the laser platform even more user-friendly, according to panelists. EW Editors' note: This session was spon- sored by Bausch + Lomb. S urgeons can use state-of- the-art IOLs and other technology to improve their outcomes in premi- um cataract and refractive surgery, according to panelists in Sunday evening's "Transitioning to Premium Cataract and Refractive Surgery" session. One product described by pan- elists was the enVista IOL (Bausch + Lomb, Bridgewater, New Jersey), which is aberration-free, glisten- ing-free, and offers predictable outcomes, said Karolinne Rocha, MD, Charleston, South Carolina. The lens is less sensitive to decen- tration compared with a negatively aberrated IOL and can work well in patients with keratoconus and irregular astigmatism, among other conditions, Dr. Rocha said. John Sheppard, MD, Norfolk, Virginia, said that the aberration-free feature of the lens gives it "tremen- dous versatility," so it can be used during transplantation surgery and possibly in uveitis or glaucoma pa- tients as well, in addition to patients with ocular trauma or inflammation. Dr. Sheppard went on to highlight various enVista features, such as its TruSight optic that makes it scratch resistant. "Your techs can push as hard as they want, and they won't scratch the lens," he said. Other features include StableFlex technol- ogy, AccuSet haptics that make the lens stable across a full range of lens powers, and a SureEdge square-edge design. At Dr. Sheppard's practice, the combination of the enVista along with his seasoned techs has led to the best predictability results with IOL calculations in a study done by Warren Hill, MD, Mesa, Arizona, according to Dr. Sheppard. P. Dee Stephenson, MD, Ven- ice, Florida, shared results from 45 eyes in 29 patients receiving the enVista MX60E IOL. Among those patients, an uncorrected distance visual acuity of 20/50 or better was achieved in 100% of patients, and 36% were 20/20 or better. A best cor- rected distance corrected visual acu- ity of 20/25 or better was achieved in 78% of study eyes. The lens had no scratches, no loading troubles during insertion, and no glistenings. Panelists praised the high quality visual results that patients can receive with the MX60E without a premium lens price. Education about the lens by a surgical coun- selor is essential to help set patient expectations, Dr. Stephenson said. Another technology highlighted was the Stellaris Elite phaco system Cutting-edge technology makes excellent surgical results achievable Dr. Sheppard highlights features of the enVista IOL. Help drive ASCRS education by taking the 6th annual ASCRS Clinical Survey T he 6th annual ASCRS Clinical Survey has been taking place at the 2018 ASCRS•ASOA Annual Meeting and will continue online until May 7. The survey is an opportunity for member ophthalmologists to weigh in on their practice patterns and opinions and drive the future of ASCRS educational programming. Data from the survey helps identify areas of educational need for future ASCRS meetings, webinars, publications, and other offerings to provide ASCRS members with the most targeted and valuable content with the ultimate goal of improving patient care. Topics covered by the survey include cataract surgery, astigmatism management, presbyopia correction, laser-assisted cataract surgery, ocular surface, inflammation and infection, corneal refractive surgery, glaucoma, retina, and young physicians. Last year more than 1,100 members took the survey, generating more than 300 unique data elements. After the results are analyzed by ASCRS Clinical Committees, key findings from the ASCRS Clinical Survey will be published in an EyeWorld supplement this fall. The results from the ASCRS Clinical Survey identify areas of educational need and track trends and changes in specific opinions and behaviors. In the ASCRS Clinical Survey 2017 EyeWorld supplement, Rosa Braga-Mele, MD, chair, ASCRS Education Committee, emphasized the importance of member participation in this initiative. "Participation in these surveys ensures that education is formatted to the needs of our membership coupled with direction from experts in the field," Dr. Braga-Mele said. "The results of this survey help ASCRS to enhance membership learning and provide members the opportunity to see how they compare with their peers." ASCRS member ophthalmologists can take this 15-minute survey at ascrs2018.questionpro.com. EW

• Cover